Atlas Trials

Study of Secukinumab With 2 mL Pre-filled Syringes

Clinical trial NCT02748863 · COMPLETED

Trial details

NCT number
NCT02748863
Sponsor
Novartis Pharmaceuticals
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Psoriasis
Start date
2016-12-12
Primary completion
2017-08-08
Enrollment
214

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.